ARCHIVES

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

Fisher, NSABP Executive Committee, File Injunction Seeking Herberman’s Removal

August 12, 1994

Personal letters: mixed reviews of Donald Pinkel’s article on Childhood Lymphocytic Leukemia

May 6, 2021

New Law Allows Texans To Self-Refer To M.D. Anderson

December 1, 1995

Shubik Subcommittee Criticizes New Study Section, Asks NCI To Hire More Epidemiologists

December 5, 1975

NCI Largely Unaffected By NIH Translational Research Center

February 11, 2011

Clearinghouse Finds Insecticide, Hair Dye Are Carcinogens

December 1, 1978